Healthcare Happenings

Written by The Rounds

As healthcare professionals, we know how difficult it is for you to keep current on all news in technology and treatments – that’s why we are here to help you. So, keep reading for the rundown on all things medicine during the week of October 3rd.

1. Shape and Size of Brain Arteries May Predict Stroke Risk

A US News article tells us that the shape and size of the blood vessels in an individual’s brain could help in predicting the risk of an aneurysm. The study found that differences of up to 1.4 in the left and right diameter of the brain arterial network equals an 80% risk of developing an aneurysm in that area. 


For more on this study click here 🔗

2. Young-Onset Type 2 Diabetes Linked With Higher Risk of Retinopathy in Men

According to abstract findings from the recent Virtual EASD meeting, it was found that the risk of retinopathy may increase with the duration of diabetes, especially in male patients diagnosed with young-onset type 2 diabetes. 


Read the full article here 🔗

Before we reveal the rest of the news…

Register for Dr. Akshay Jain’s session on addressing the highlights of the 2021 European Association for the Study of Diabetes Annual Meeting beginning October 11th in The Rounds network!

Join the discussion here!

3. Pregnant Women Benefit From Getting COVID-19 Vaccination

Results of a recent study showed that pregnant women are at great risk of contracting severe respiratory infections, therefore making them increasingly more susceptible to the Novel CoronaVirus. Those pregnant women that are vaccinated for COVID-19 stand a better chance of overcoming the sickness. 


Further insights on this study can be found here 🔗

4. PARP Inhibitors for Second-Line Maintenance in Ovarian Cancer

Two board-certified oncology pharmacists reviewed the importance of PARP inhibitors for second-line maintenance in treating ovarian cancer. 


Click here to watch the video 🔗

5. Two of BioNTech COVID-19 Vaccines Effectively Prevent Hospitalization for at Least 6 Months

New research published in the The Lancet has found that the efficacy of the second dose COVID-19 vaccine against the virus-related hospitalization for all variants remains high for at least six months. 


Learn more here 🔗

Visit The Rounds on Twitter and Instagram for more industry news and updates. 💻

Connect with your medical peers and discuss these topics in a secure space in The Rounds network!